SA pledges $1.2-million towards global hunt for Covid-19 vaccine and treatment
About €7.4-billion (about R148-billion) was pledged by countries from around the globe for research and development for vaccines, diagnostics and therapeutics in the global fight against Covid-19.
South Africa pledged $1.2-million (about R22-million) towards global research and development for vaccines, diagnostics and therapeutics initiative in the fight against the Covid-19 (coronavirus).
On Monday, President Cyril Ramaphosa was part of 40 heads of state who joined forces in a virtual pledging conference supporting the Covid-19 global response international pledging event.
African Union and European Union members were part of the pledging conference convened by the Global Preparedness Monitoring board.
Ramaphosa said Covid-19 was a health emergency that has affected most global nations, but developing countries were particularly vulnerable to its impact.
ALSO READ:Foundation to continue feeding Olievenhoutbosch residents
He said the fight against Covid-19 needed coordinated and consistent international action for all countries to be sufficiently equipped to fight against the virus.
“We call on all countries to make tangible commitments to bolster the global effort, but in particular to support countries that bear the brunt of poverty, inequality and underdevelopment.
“Africa has responded to the coronavirus pandemic with urgency and purpose.
“The African Union has established a Covid-19 response fund to direct resources towards the continent’s response. To date, a total of $61-million (about R1.15-billion) has been committed to the fund and to support the Africa Centres for Disease Control and Prevention.
“In addition to the investments we have made to these and other research initiatives, South Africa is committing an amount of $1.3 million (about R24-million) at this historic pledging conference,” he said.
On home-ground, he said, African countries are supporting each other through regional coronavirus task forces to oversee screening, detection and diagnosis, infection prevention and control.
“South Africa is making significant investments in science and innovation to fight the Covid-19 pandemic, and is participating in several research initiatives with partners across the world and to support African researchers.”
He said the doors of South Africa’s Biovac Institute facilities were open to support the global effort to develop, manufacture and distribute a Covid-19 vaccine.
“Now, more than ever, the world needs solidarity and cooperation to mobilise and guide investments, and drive delivery towards equitable access for new Covid-19 diagnostics, therapeutics and vaccines.
“Working together, we shall overcome this pandemic.”
ALSO READ:Tshwane needs contract healthcare professionals
The pledges made at the conference amounted to €7.4-billion, money which is set to be given to different global health institutions to support its global fight against Covid-19, including the World Health Organisation.
* Notice: Coronavirus reporting at Caxton Local Media aims to combat fake news
Dear reader,
As your local news provider, we have the duty of keeping you factually informed on Covid-19 developments. As you may have noticed, mis- and disinformation (also known as “fake news”) is circulating online. Caxton Local Media is determined to filter through the masses of information doing the rounds and to separate truth from untruth in order to keep you adequately informed. Local newsrooms follow a strict pre-publication fact-checking protocol. A national task team has been established to assist in bringing you credible news reports on Covid-19.
Readers with any comments or queries may contact National Group Editor Irma Green (irma@caxton.co.za) or Legal Adviser Helene Eloff (helene@caxton.co.za).
Do you have more information about the story? Please send us an email to editorial@rekord.co.za or phone us on 083 625 4114.
For free breaking and community news, visit Rekord’s websites:
For more news and interesting articles, like Rekord on Facebook, follow us on Twitter or Instagram
